Results 111 to 120 of about 29,629,799 (238)
Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children.
Immunity to the sexual stages of Plasmodium falciparum can be induced during natural infections. Characterization of this immunity may facilitate the design of a transmission-blocking vaccine (TBV).
Bousema, T. +20 more
core +1 more source
Repurposing Drugs for Malaria through a Human Dose Prediction: A Case Study with Berzosertib
Repurposing drugs whose clinical safety has been established offers a valuable approach to reduce the cost and time associated with the development of new drugs for malaria. Here, we investigate the potential to repurpose the anticancer kinase inhibitor berzosertib for the treatment of malaria, by assessing whether a predicted efficacious human dose ...
Devasha Redhi +5 more
wiley +1 more source
Serum enzymes activities in Plasmodium falciparum infection in Southern Pakistan [PDF]
Objective: Serum levels of lactate dehydrogenase (LDH),aspartate aminotranferase (AST), alanine aminotransferase(ALT), and alkaline phosphatase (ALP) were assessed todetermine the liver functions of patients infected withPlasmodium falciparum. The enzyme
Koay Yen Chin +3 more
doaj
Background The disease burden of Plasmodium falciparum malaria illness is generally estimated using one of two distinct approaches: either by transforming P. falciparum infection prevalence estimates into incidence estimates using conversion formulae; or
Ursula Dalrymple +11 more
doaj +1 more source
ABSTRACT Background and Aims The RTS,S/AS01 malaria vaccine (MV) was introduced in Cameroon on 22 January 2024 in 42 of 200 health districts, including three in the Littoral Region (Edea, Japoma and Mbanga). This study describes early trends in severe malaria among children under 5 years of age in these three districts of the Littoral Region and ...
Alex Stéphane Ndjip Ndjock +6 more
wiley +1 more source
Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte. [PDF]
BACKGROUND: The asexual blood stages of the human malaria parasite Plasmodium falciparum produce highly immunogenic polymorphic antigens that are expressed on the surface of the host cell.
Christopher J. Drakeley +26 more
core +1 more source
Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria
ABSTRACT Malaria is a global health threat, with an estimated 282 million cases and 610,000 malaria‐associated deaths reported in 2024. Most mortality is due to infection by Plasmodium falciparum parasites, with the highest burden occurring in Sub‐Saharan Africa.
Wisam A. Dawood +7 more
wiley +1 more source
Plasmepsins as Antimalarial Drug Targets—Then, Now, and the Future
ABSTRACT Malaria is a devastating disease caused by Plasmodium parasites. Plasmodium parasites express ten cathepsin D‐like aspartyl proteases, called plasmepsins (PMs). These PMs have diverse roles fulfill diverse functions throughout the parasite's lifecycle, though several exhibit functional redundancies. Among them, PMV, PMIV, and PMX are essential
Brad E. Sleebs
wiley +1 more source
PfHPRT: a new biomarker candidate of acute Plasmodium falciparum infection.
Plasmodium falciparum is a protozoan parasite that causes human malaria. This parasitic infection accounts for approximately 655,000 deaths each year worldwide. Most deaths could be prevented by diagnosing and treating malaria promptly.
Conway, David J +10 more
core +1 more source
SEROLOGICAL AND PARASITOLOGICAL OBSERVATIONS ON MALARIA IN SOUTHERN IRAN [PDF]
In the course of serological and parasitological studies of malaria, 1,018 persons were examined. They were from four different areas (A, B, C and D) in the region of Bandar Abbas and 1-1ina), southern Iran, where malaria is still endemic.
Gh. H. Edrissiaon, A. Afshar
doaj +1 more source

